CTAS
59
6
MAR
69
13
TJX
46
3
BSX
63
2
D
35
-6
MMC
60
5
EQT
39
9
IR
71
10
AVY
47
-6
PCAR
64
8
PVH
63
4
VLO
40
7
CMS
54
-3
IBM
50
4
CFG
78
20
HBI
49
-3
WM
76
2
SYY
47
2
DG
21
-6
PM
50
-16
CTAS
59
6
MAR
69
13
TJX
46
3
BSX
63
2
D
35
-6
MMC
60
5
EQT
39
9
IR
71
10
AVY
47
-6
PCAR
64
8
PVH
63
4
VLO
40
7
CMS
54
-3
IBM
50
4
CFG
78
20
HBI
49
-3
WM
76
2
SYY
47
2
DG
21
-6
PM
50
-16
Financhill
Back

Citius Oncology Vs. Dave Industry Stock Comparison

Sell
1

CTOR
Citius Oncology

Last Price:
1.23
Seasonality Move:
--
Buy
79

DAVE
Dave

Last Price:
45.41
Seasonality Move:
103.59%
Sell
1
Citius Oncology (CTOR) is a Sell

Is Citius Oncology a Buy, Sell or Hold?

  • The current Citius Oncology [CTOR] share price is $1.18. The Score for CTOR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • CTOR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
79
Dave (DAVE) is a Buy

Is Dave a Buy, Sell or Hold?

  • The current Dave [DAVE] share price is $45.87. The Score for DAVE is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • DAVE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CTOR Stock Price Chart

What is Citius Oncology's stock price today?

  • The Citius Oncology share price today is $1.18
    The current trend is relatively stagnant and CTOR is experiencing slight selling pressure.

DAVE Stock Price Chart

What is Dave's stock price today?

  • The Dave share price today is $45.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAVE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CTOR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 44.88 Sell
Chaikin Money Flow: -54470 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.03 - 1.23) Buy
Bollinger Bands (100): ( - ) Buy

DAVE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 62.43 Buy
Chaikin Money Flow: 1584842 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.77 - 44.59) Buy
Bollinger Bands (100): (33.52 - 41.52) Buy

CTOR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.16 Buy
20-day SMA: 1.14 Buy
50-day SMA: 1.38 Sell
200-day SMA: 0 Buy
8-day EMA: 1.16 Buy
20-day EMA: 1.19 Sell
50-day EMA: 1.43 Sell
200-day EMA: 0.04 Buy

DAVE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 41.58 Buy
50-day SMA: 39.74 Buy
200-day SMA: 36.11 Buy
8-day EMA: 40.41 Buy
20-day EMA: 40.66 Buy
50-day EMA: 39.93 Buy
200-day EMA: 34.24 Buy

Citius Oncology Earnings Growth & CTOR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dave Earnings Growth & DAVE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.60 per share.

Citius Oncology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dave Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):